LPCN

Lipocine Inc.

2.54 USD

Last updated Dec 3, 01:35 UTC

Yesterday HIGH

$2.75

Yesterday LOW

$2.43

52w HIGH

$10.34

52w LOW

$2.31

EPS

-1.27

PE

-2.00

Next Earnings

Mar 8, 2024

Overview News Government Trades

Lipocine Inc. stock is down -1.55% since 30 days ago. The next earnings date is Mar 8, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 27.27% of the previous 10 December’s closed higher than November.

Lipocine focuses on the development of pharmaceutical products for the treatment of neuroendocrine and metabolic disorders. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Its lead product candidate is TLANDO, an oral testosterone replacement therapy.

Stock Exchange

NASDAQ

Sector

Manufacturing

Industry

Pharmaceutical Products

Headquarters

Newark, United States Of America

Website

lipocine.com

Lisa Levin

Tue Apr 4, 2023

Why AMC Entertainment Holdings Shares Are Trading Lower By 25%; Here Are 20 Stocks Moving Premarket

Gainers AMC Entertainment Hldg Pref Equity Units (NYSE: APE) gained 28.4% to $1.90 in pre-market trading. AMC Entertainment Holdings stated it agreed to settle litigation and move forward with converting its preferred stock into common shares.
Charles Gross

Mon Apr 3, 2023

Lipocine Said First Participant Has Been Dosed In Pilot Clinical Bridge Study Of LPCN 1154 And Approved Injectable Brexanolone; Topline Study Results Expected In H1 2023

https://www.sec.gov/Archives/edgar/data/1535955/000149315223010483/ex99-1.htm
Lisa Levin

Mon Mar 27, 2023

Around $3M Bet On This Basic Materials Stock? Check Out These 4 Penny Stocks Insiders Are Buying

The Dow Jones closed higher by more than 100 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Lisa Levin

Mon Mar 20, 2023

Nogin And 2 Other Stocks Under $2 Insiders Are Aggressively Buying

The Dow Jones traded higher by around 300 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Benzinga Insights

Mon Mar 13, 2023

12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights

Fri Mar 10, 2023

Stocks That Hit 52-Week Lows On Friday

On Friday, 497 companies set new 52-week lows.
Benzinga Insights

Fri Mar 10, 2023

12 Health Care Stocks Moving In Friday's Intraday Session
Happy Mohamed

Fri Mar 10, 2023

CORRECTION: Lipocine Q4 EPS $(0.03), Inline

Lipocine (NASDAQ:LPCN) reported quarterly losses of $(0.03) per share which met the analyst consensus estimate. This is a 121.43 percent decrease over earnings of $0.14 per share from the same period last year.
Happy Mohamed

Fri Mar 10, 2023

Lipocine Q4 EPS $(0.03), Inline

Lipocine (NASDAQ: LPCN) reported quarterly losses of $(0.03) per share which met the analyst consensus estimate. This is a 121.43 percent decrease over earnings of $0.14 per share from the same period last year.
Benzinga Insights

Thu Mar 9, 2023

12 Health Care Stocks Moving In Thursday's After-Market Session